Brett K. Haumann's most recent trade in Theravance Biopharma Inc was a trade of 35,672 Ordinary Shares done at an average price of $18.8 . Disclosure was reported to the exchange on Feb. 20, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma Inc | Brett K. Haumann | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.79 per share. | 20 Feb 2021 | 35,672 | 242,499 (0%) | 0% | 18.8 | 670,277 | Ordinary Shares |
| Theravance Biopharma Inc | Brett K. Haumann | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 20 Nov 2020 | 4,639 | 278,171 (0%) | 0% | 17.2 | 79,837 | Ordinary Shares |